Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Americas
Law firm Goodwin Procter has hired William Growney and Cindy McAdams as partners in the firm’s technology and life sciences group in Silicon Valley.   20 October 2015
Americas
US President Barack Obama has been urged by several non-government organisations to permanently exempt the world’s least developed countries from having to grant patents for pharmaceutical products.   20 October 2015
Americas
The US Court of Appeals for the Federal Circuit has declined to hear the Amgen v Sandoz ‘patent dance’ dispute en banc.   19 October 2015
Americas
A counsel for pharmaceutical company Eli Lilly has said that recent court decisions, including Ariosa v Sequenom, will create a bar to innovation.   16 October 2015
Americas
A director of a research initiative pioneered by pharmaceutical company GSK has said that recognising the initial owner of intellectual property is at the heart of its priorities.   16 October 2015
Americas
The US’s consul general in Rio de Janeiro has urged the US and Brazilian governments to work together to tackle the long delay in biotechnology-related patents being granted at Brazil’s intellectual property office.   15 October 2015
Americas
Pharmaceutical company Ranbaxy Laboratories, a subsidiary of Sun Pharma, has confirmed it has settled a patent lawsuit filed against Allergan.   15 October 2015
Americas
Law firm BakerHostetler has hired Allen Sokal as counsel in the firm’s intellectual property group in Washington, DC.   15 October 2015
Biotechnology
The Dutch lobby to amend Directive 98/44/EC on the legal protection of biotechnological inventions will severely damage the ability of the biotech sector to innovate—and for no tangible reason, says Annemiek Verkamman of HollandBIO.   15 October 2015
Asia
The High Court of Australia’s decision in Myriad has led some observers to hit the panic button and demand immediate legislative change, but only isolated naturally-occurring genes are affected and the ruling should be read in that light, says Grant Shoebridge of Shelston IP.   15 October 2015